July 2024 - Page 69 of 98 - Sarkari Doctor

SGLT2 inhibitors and GLP1 receptor agonists combo tied to additional heart and kidney benefits: Lancet

New research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and kidney disease in patients with diabetes. Findings were published today in The Lancet Diabetes & Endocrinology and presented in May at the 61st European Renal Association Congress in Stockholm, Sweden.

SGLT2is, also called gliflozins, are a class of drug that lower blood glucose by increasing its excretion in the urine, while GLP-1RAs, such as Ozempic, work by enhancing insulin release and sensitivity. Both classes of medicine have each been shown to improve cardiovascular outcomes. Although small, relatively short-term trials have suggested that using these medicines together improves blood glucose control, their combined effects on heart disease and kidney failure are less clear.

Researchers involved in the SGLT2 Inhibitor Meta-analysis Cardio-Renal Trialists’ Consortium (SMART-C) pooled data across 12 large-scale, placebo-controlled trials of SGLT2is involving 73,238 patients with diabetes, 3,065 of whom were already receiving GLP1-RAs. The meta-analysis showed that the benefits of SGLT2is were observed independent of GLP1-RA use.

SGLT2is reduced the risk of major adverse cardiovascular events (myocardial infarction, stroke, or cardiovascular death) by 11% and hospitalisation for heart failure or cardiovascular death by 23% versus placebo, even when added to GLP1-RAs. SGLT2is also reduced the risk of chronic kidney disease progression by 33% when added to GLP1-RAs and slowed the annual loss of kidney function by almost 60% when added to GLP-1RAs. No new safety concerns were identified when SGLT2is and GLP-1RAs were used in combination.

Clinical Associate Professor Brendon Neuen, Senior Research Fellow at The George Institute for Global Health, Director of Kidney Trials at Sydney’s Royal North Shore Hospital, and lead author on the paper said, “Given the rapidly expanding indications for the use of GLP-1 receptor agonists, it was important to look at their effects with SGLT2 inhibitors. This study represents the largest and most comprehensive assessment of clinical outcomes for this combination of medicines.”

A/Prof Neuen added that both classes of medicines work independently of each other: “SGLT2 inhibitors have clear protective effects against heart failure and chronic kidney disease, while GLP-1 receptor agonists can reduce the risk of heart attack, stroke, and also kidney disease – as recently demonstrated in the landmark FLOW trial. Our findings support using this combination to further improve outcomes in patients with type 2 diabetes who meet guideline recommendations for both therapies.”

Diabetes is a known risk factor for cardiovascular and kidney disease, with impaired glucose control causing damage to blood vessels in the heart and kidneys. Many patients with diabetes live with cardiovascular disease or chronic kidney disease, with prevalence increasing in the years following a diabetes diagnosis.

SMART-C is co-chaired by A/Prof Brendon Neuen and Prof Hiddo Heerspink of The George Institute for Global Health.

Reference:

Carlos Escobar Cervantes, SGLT2 inhibitors and GLP-1 receptor agonists: the definitive combination?, The Lancet Diabetes & Endocrinology, https://doi.org/10.1016/S2213-8587(24)00183-9.

What is role of ultrasonographic measurement of gastric antral volume and pH in aspiration prophylaxis in low risk surgery patients?

The aspiration of gastric contents is regarded as a highly concerning complication during anesthesia for patients undergoing diverse surgical procedures. Recent study investigated the role of preoperative pharmacological prophylaxis in preventing aspiration pneumonitis under general anesthesia in low-risk patients. The researchers conducted a single-center, double-blinded, randomized controlled trial with 200 adult patients scheduled for elective surgical procedures under general anesthesia.

The patients were randomized into two groups – a prophylaxis group that received oral famotidine and metoclopramide, and a no-prophylaxis group that did not receive any prophylaxis. All patients were kept fasting for 8 hours prior to surgery. The primary outcome was to compare the difference in residual gastric volume calculated based on USG guided gastric antral cross-sectional area (CSA) between the two groups. The secondary outcomes were to compare the gastric pH and incidence of aspiration pneumonitis.

The results showed that the gastric antral CSA and calculated gastric volume were comparable between the prophylaxis group (2.56 cm2 and 19.67 ml) and the no-prophylaxis group (3.12 cm2 and 20.11 ml). Although there was a statistically significant decrease in gastric pH in the no-prophylaxis group, it was not clinically significant to increase the risk of aspiration pneumonitis. None of the patients in either group had a gastric volume greater than 1.5 ml/kg, which is considered the threshold for aspiration risk. When analyzed using the Roberts and Shirley criteria, 38% of patients in the prophylaxis group and 44% in the no-prophylaxis group had a gastric volume ≥0.4 ml/kg, but there was no significant difference in the risk of aspiration between the groups.

The researchers concluded that in an adequately fasted low-risk surgical population, the amount of residual gastric volume and pH were similar and below the threshold to cause aspiration pneumonitis, regardless of the use of aspiration prophylaxis. They suggest that preoperative pharmacological aspiration prophylaxis may not be necessary in this patient population if adequate fasting is ensured.

Key Points –

The key points from the research article are:

1. The study investigated the role of preoperative pharmacological prophylaxis (famotidine and metoclopramide) in preventing aspiration pneumonitis under general anesthesia in low-risk patients. It was a single-center, double-blinded, randomized controlled trial with 200 adult patients scheduled for elective surgical procedures under general anesthesia.

2. The results showed that the gastric antral cross-sectional area, calculated gastric volume, and incidence of aspiration pneumonitis were comparable between the prophylaxis group and the no-prophylaxis group. Although there was a statistically significant decrease in gastric pH in the no-prophylaxis group, it was not clinically significant enough to increase the risk of aspiration pneumonitis.

3. The researchers concluded that in an adequately fasted low-risk surgical population, the amount of residual gastric volume and pH were similar and below the threshold to cause aspiration pneumonitis, regardless of the use of aspiration prophylaxis. They suggest that preoperative pharmacological aspiration prophylaxis may not be necessary in this patient population if adequate fasting is ensured.

Reference –

Kannamani B, Panneerselvam S, Rudingwa P, Badhe AS, Govindaraj K, Ramamoorthy SV. Comparison of ultrasonographic measurement of gastric antral volume and pH with or without pharmacological acid aspiration prophylaxis in low‑risk surgical patients – A randomized clinical trial. J Anaesthesiol Clin Pharmacol 2024;40:299‑304

MCC NEET MDS Counselling 2024: Here are FAQs for Candidates

New Delhi- For the National Eligibility and Entrance Test- Master of Dental Surgery (NEET-MDS) Counselling 2024, the Medical Counselling Committee (MCC) has released the Frequently Asked Questions (FAQs) for all the candidates seeking admission to MDS courses.

Below are the FAQs-

Q1 When will the online allotment process for this year start?

A Online allotment process will start as per the counselling Schedule for PG online Counseling for the current academic year. Please See the Schedule available on the MCC official website.

Q2 Do I have to report to any counselling centre for registration or choice filling?

A No. Online registration and choice filling can be done from a place of convenience (Including from home) using the internet. Uninterrupted internet facilities should be ensured.

Q3 What information do I require for online registration?

A Please note that you will be asked to fill in some of the information (we are not showing it here for security reasons) that you have given in your application form of NBE, admit card of examination during online registration and provided by the examination conducting agency (NBE). Therefore, keep a copy of your application form and admit card ready for reference. These documents may be retained as they may be required till you complete your PG course.

Also Read: MCC NEET MDS 2024 Counselling registrations begin: Know how to apply

Q4 How do I get the password for logging in?

A During the process of online registration, you will generate your own password. Candidates are advised to keep the password that they have created, confidential to them till the end of the counselling process. They can change the password after creating it. Password is very important for participating in the online allotment process. Sharing of passwords can result in their misuse by somebody else, leading to even exclusion of genuine candidates from the online allotment process.

Q5 How much time will I be given to join the allotted course?

A Candidates who are allotted seats will be required to join the allotted college/course within the stipulated time from the date of allotment as mentioned in the counselling schedule. However, candidates are advised to join as early as possible and not to wait for the last day of joining, due to different schedules of holiday/working hours at various Medical/Dental Colleges, also keeping in view that Medical/Dental colleges will have to furnish information about joining/non- joining status of candidates on Medical Counseling Committee portal. In some of the Colleges, it may take 2 to 3 days’ time for completion of admission formalities.

Q6 What documents are required at the time of joining an allotted Medical / Dental College?

A Original documents required at the time of joining in allotted Medical/Dental College are as mentioned below-

1 Allotment Letter issued by MCC.

2 Admit Card issued by NBE.

3 Result/Rank Letter issued by NBE.

4 Mark Sheets of MBBS/BDS 1st, 2nd & 3rd Professional Examinations.

5 MBBS/ BDS Degree Certificate/ Provisional Certificate.

6 Internship Completion Certificate/Certificate from the Head of Institution or College that the candidate shall complete the Internship by 31st March, of the year of admission/ or if required the date as decided by the Competent Authority.

7 Permanent/provisional Registration Certificate issued by MCI/NMC or DCI/State Medical or Dental Council. A provisional Registration Certificate is acceptable only in cases where a candidate is undergoing an internship and likely to complete the same on or before 31st March of the year of admission.

8 High School/Higher Secondary Certificate/Birth Certificate as proof of date of birth.

9 Candidates allotted seat must carry one of the identification proofs (ID Proof) to the allotted college at the time of admission (as mentioned in the information Bulletin published by the National Board of Examinations (NBE) for NEET i.e. PAN Card, Driving License, Voter ID, Passport or Aadhaar Card).

10 The Candidate should also bring the following certificates, if applicable-

i SC/ST Certificate issued by the competent authority (in the format as specified in the Information Bulletin) and should be in English or Hindi language. Sub-caste should be mentioned in the certificate. The translated certificate must be certified by a Gazetted Officer.

ii EWS Certificate as per the Central Govt. Norms (in the format as specified in the Information Bulletin) and should be in English or Hindi language. The translated certificate must be certified by a Gazetted Officer.

iii OBC certificate issued by the competent authority. The sub-caste should tally with the Central List of OBC. The OBC candidates should not belong to the Creamy Layer. The translated certificate must be certified by a Gazetted Officer.

iv Disability Certificate issued from a duly constituted and authorized Medical Board for 21 Benchmark Disabilities as per the Rights of Persons with Disability Act,2016 and NMC Norms. No other certificate, issued by any other Authorities/ Hospital will be entertained.

v NRI/OCI sponsored certificates etc must bring in original at the time of reporting.

Also Read: MCC to conduct NEET MDS Counselling of Priority- III, IV, V candidates into AFMS PG Teaching Institutes from this year, all details here

Q7 What are the various fees to be paid at the time of registration?

A The following table explains the answer to the question-

S.NO	PAYMENT SCHEME FOR DIFFERENT CATEGORIES	NON-REFUNDABLE (FEES)		REFUNDABLE SECURITY
S.NO	PAYMENT SCHEME FOR DIFFERENT CATEGORIES	UNRESERVED (UR/EWS CANDIDATES)	RESERVED (ST/SC/OBC/PwD)	UNRESERVED (UR/EWS CANDIDATES)	RESERVED (ST/SC/OBC/PwD APPLICABLE-JAIN/MUSLIMS)
1	AIQ	Rs. 1000/-	Rs.500/-	Rs. 25000/-	Rs. 10000/-
2	Deemed Universities	Rs. 5000/-	Rs. 5000/-	Rs. 2,00,000/-	Rs. 2,00,000/-

Q8 What are the circumstances wherein the refundable security deposit will be forfeited?

A Under the following circumstances the refundable security deposit will be forfeited by MCC-

i. Where a Candidate has been allotted a seat in Round 2 or subsequent rounds and does not report at the allotted college to complete the admission process.

ii. The Security Deposit will be forfeited if the admission gets cancelled after allotment due to any reason. E.g., in case the candidate gives wrong information at the time of registration on the basis of which a seat may be allotted and later cancelled by the Admission Authorities at the time of reporting or fails to produce the required documents at the time of admission.

Also Read: MCC Releases NEET MDS 2024 Counselling Schedule, Sessions to Commence from August 1

Q9 In case the candidate must apply for both AIQ and for Deemed University should the candidate pay the fee for both?

A No, in such case the candidate has to pay only the higher fee i.e. of Deemed University Rs.5000/-and 2 Lakh Refundable Security Deposit.

Q10 What are the instructions regarding OBC, SC, ST, PwD & EWS certificates?

A In case the candidate fails to produce proper Caste, PwD and EWS Certificate, if applicable, at the allotted Medical/Dental College then he/she will not be permitted to join and the seat will be cancelled by the allotted Medical / Dental College. Further, the reservation of seats under the PwD Category is 5% in AIQ and the 21 Benchmark Disabilities as envisaged under the regulations of the Rights of Persons with Disabilities Act 2016 and as per NMC norms, have been included presently, where only the lower motor disabilities were included earlier. The qualified Persons with Disability (PwD) candidates should get themselves certified at one of the Disability Assessment Boards, constituted in various states. The extent of “specified disability” in a Person with Disability (PwD candidate) shall be assessed in accordance with these guidelines for the purpose of issuing Disability Certificate and at the time of admission to the college. Further, all the PwD candidates participating in the PG Counselling are required to get themselves assessed for their disability and obtain a Disability Certificate from any one of the designated Disability Centres.

Q11 Is there any restriction for filling up a number of choices of Institutions (Colleges) or subjects in the choice filling form?

A No, you can give as many choices as you wish. However, choices should be in order of preference, as the allotment is done on the basis of choices submitted by the qualified candidate in order of preference given by the candidate and as per availability. However, the participating candidates should fill in the choices up to a total of 30-40 choices.

Q12 Can I have some idea about the seat I am likely to get at my rank?

A Yes, the previous year’s allotment results are available on the MCC website. This will only be indicative (without any guarantee for the current year).

Also Read:MCC Releases Tentative Schedule for NEET MDS Counselling 2024, Registrations from July 1st, All details here

Q13 Is it necessary to fill up the choices and lock the choices to get the seat allotted? Or I will be allotted a seat automatically from available seats?

A After online registration (registration is compulsory to take part in the online allotment process), you have to fill in the choice of subjects and Institutions/colleges in order of preference. Once choices are filled in, it can be modified before locking it. During the choice locking period, it is necessary to lock the choices to get a print of your submitted choices. If the candidate does not lock the choice submitted by him/her, they will be automatically locked on the notified date at the notified time, however, you will be allowed to take a print of your choices after locking, but you will not be permitted to modify your choices after locking.

Q14 Is it necessary to join the allotted Medical / Dental College in Round 1 to get a chance to participate in the next round (2nd Round)?

A If a candidate does not report at the allotted institute in Round 1, this will be considered a ‘Free Exit’ (an option available only in Round 1). However, candidates who have not joined (the Round-1- 1 allotted seat) by availing the free exit option may participate again in Round 2 after logging in with their earlier Registration details. In case a candidate wants to ensure /retain his/her Round -1 seat and wants to upgrade his/her allotted seat, he/she should join the Round-1 seat and give willingness for Up-gradation at the allotted college. However, if a candidate wants to participate directly in Round 2 without retaining the Round 1 seat he/she may not join the college and do choice filling for Round 2 since Round 1 has a free exit option. In the above-said case, he/she cannot claim the Round 1 seat.

Q15 What is the second round of the online allotment process & who is eligible for the same?

A 1 Round-2 of the online allotment process is a fresh allotment and up-gradation round wherein the candidates who have not registered initially during Round 1 can register and participate in round-2.

2 Candidates who have joined Round-1 allotted seats can opt for up-gradation during Round- 2. And, candidates who were allotted Round-1 seat but did not join it, can also participate without fresh registration.

Also Read: Supreme Court notice to NBE, MCC over plea seeking release of NEET PG Question Paper, Answer Key

Q16 Do I have to fill up choices of subject and College to participate in the second Round of allotment process separately?

A Yes, for Round 2 and Mop Up round of Deemed/ Central Universities, candidates are required to submit fresh choices. During the second round of the online allotment process, the choice of higher preference will be considered for up-gradation for those candidates who are given the option to upgrade their choice at the time of admission at the allotted Medical/Dental College. During Round 2, fresh allotment will be considered for those eligible candidates who could not be allotted a seat due to the non-availability of a seat in Round 1, (subject to availability of a seat) and for candidates who have logged in again in Round 2 after Free Exit from Round- 1.

Q17 If a sufficient number of qualified PwD candidates are not available then, what will happen to those unallotted PG seats, reserved for PwD candidates?

A The un-allotted PG seats earmarked for UR-PwD, SC-PwD, ST-PwD and OBC- PwD will be reverted/converted to respective categories like SC-PwD to SC and so on Mop Up round of allotment process after processing choices to PwD category candidates in Mop Up Round.

Q18 If I give consent for the up-gradation of my choice during Round 1 and if my choice is upgraded, is it necessary to join at college allotted during the second round? Or in case I change my decision of upgrading choice, can I continue to study in college allotted through the first round of allotment?

A In case the candidate is allotted a seat during the Round-1 of allotment process and his choice is upgraded in Round 2, the seat allotted during the first round will be automatically cancelled immediately (and allotted to somebody else eligible as per merit) and the candidate will have to join the college/seat allotted during the second round. If the candidate does not join the college/seat allotted during the second round, within the stipulated time, as per schedule, his/her Refundable Security Deposit will be forfeited. After joining the allotted institute in Round 2 the candidate will not be eligible to participate in any other round of counselling (For AIQ as well as Deemed/Central University/DNB and States counselling). The names of such candidates who have joined in Round 2 of AIQ / Deemed / Central Universities/DNB will be circulated to all state counselling authorities to prohibit them from participating in any other counselling. Similarly, the candidates who have joined a seat upto round 2 of States will not be eligible to participate in the counselling conducted by MCC of DGHS in compliance with the directions of the Hon’ble Supreme Court of India and their names will be circulated by all the States to MCC of DGHS.

Seat can also be up-graded in the same college by change of category (i.e. ST / SC / OBC to UR or PwD to non-PwD seat) in such a case the candidate has to take fresh admission on the up-graded seat.

Also Read: Doctors at HCGMCC successfully remove Large Neuroectodermal Tumour from neck of 56-year-old patient

Q19 If I am given the option to participate in ROUND-2 at the time of joining college from the first round allotment, but later change my decision and want to continue studying at the already allotted Medical / Dental College of Round-1, what is the procedure to avoid change (cancellation) of already allotted college/seat?

A In such a case candidate need not fill any fresh choices for Round 2 and the earlier seat will be retained.

Q20 If I forget the password that I have created during the process of registration, how to retrieve it?

A To retrieve the forgotten password, the system facilitates the following process-

The candidate is required to enter the information that he/she filled in at the time of registration and then the security question & answer thereon to be entered as given during the New Candidate registration process. The above data submitted by the candidate will be validated with the registered candidates’ database. If the above entries match, then only the candidate would be permitted to enter a new password to proceed further.

Q21 In case I have a Birth Certificate/Caste Certificate/other certificate(s) in the regional language, will it be acceptable at the time of reporting/joining?

A Certificates issued by the competent authority should be in English or Hindi language. Please remember that some of the states insist on a certificate in English language only. Candidates are advised to carry a Certified Copy of the English version of the original certificate, in case the certificate issued is in another language than English along with an original certificate.

Q22 If there is a discrepancy in the spelling of the name in the documents and application form, what do I do?

A If there is a discrepancy in spelling in documents candidate must carry proof that the documents belong to the same person, in the form of an affidavit/undertaking.

Q23 What about the condition of Stipend/fee structure/course duration/bond amount /rendering of service in rural/tribal areas / other conditions?

A Stipend /fee structure/ course duration/bond amount/rendering of service in rural/tribal areas/other conditions etc. may vary from State to State and Institute to institute.Someseatsmaybeapproved/permitted, but they are not recognised by CMI. However, MCC does not differentiate between Recognized/ Permitted Seats and the allotment is made only on MCI/NMC/DCI APPROVED Seats. The allotment made through the online allotment process will be firm and final as per the Hon’ble Supreme Court’s directions. Therefore, the candidates should well examine these points before opting for a seat at a medical/dental college. The Medical Counseling Committee(MCC) shall neither be responsible nor shall entertain any case on the above grounds, if any. The information received from various participating Medical/ Dental Colleges has been made available on the Ministry of Health & Family Welfare / MCC website (under the Medical Counseling – Post-graduate Counseling – Information about college, fee, bond information etc.). Candidates are advised to visit the website of the college/ institution to check the information. In case they require any additional information, they can contact the college/institution by telephone. MCC has no role in the fixation of the Fee Structure of participating colleges including Deemed Universities. Therefore, the MCC of DGHS will not entertain any request or complaint regarding the Fee Structure of participating colleges including Deemed Universities. The Candidates may also verify the address of the selected colleges at the time of choice-filling.

Q24 How to use the registration and Choice filling forms on the website?

A Candidates will have to log on to the website to get registered (Registration facility will open on dates as mentioned in the Schedule) and then fill in choices. It is advised that after going through the seat matrix, a tentative list may be prepared first as per your preference of subjects and colleges, before attempting to fill choices online.

Q25 Difficulty in login, what may be the problem(s)?

A Follow the instructions about the use of browser (Mozilla Firefox, Internet Explorer – (Latest Version), Google Chrome), use of the same spellings, the same format of the date (Use digits for day, month and year within between) as in application form submitted to National Board of Examination (NBE), New Delhi. The internet connection should be uninterrupted. If an internet connection interruption takes place, the IP address which is being monitored will change and a session expired message will be displayed. Please try to log in from another computer from which other candidate(s) have logged in successfully, if possible.

Also Read: MCC NEET MDS 2024 Counselling registrations begin: Know how to apply

Q26 I have difficulty Creating a Password, what may be the problem(s)?

A Creation of a password should be as per the password policy. Please follow the password policy. Please use the internet browser as suggested in the user manual, as it is difficult to log in from some of the other browsers. While creating a password avoid using the Caps Lock key, instead of the Caps Lock use the shift key.

Q27 When I try to log in for choice filling/submission, it says wrong roll number password, what may be a problem(s)?

A This can happen if the Roll Number typed is incorrect or the password typed is incorrect. Password is case sensitive, therefore use the password which was created by the user exactly same as typed while creating. In case the password is forgotten, try to generate a new password by using the security question and its answer.

Q28 Can I modify my choices during the choice submission period for counselling?

A Yes, you can modify, add or delete your choices during this period, before you lock your choices. However, the registration (of New Users) is permitted up to the specified date and time specified in the counselling Schedule, only. Please note that you have to lock your choice by the date and time specified in the Counseling Schedule. If, not then the choices will be automatically locked by the server as per the schedule.

Q29 I have not locked my choices before the time specified in the counselling schedule on the last date of choice locking, what will happen to my choices?

A The choices submitted and saved by you will be locked by the system at the time of the last date/date of choice locking as mentioned in the Counseling Schedule, automatically. Once locked, the choices cannot be altered/modified/changed.

Also Read: BFUHS Invites Applications for NEET MDS 2024 admissions, details

Q30 How can I get a printout of my choices that which system has locked?

A After the specified time of the last date/date of choice locking (or after choice locking) printout can be taken from the MCC website after login by the Candidate, a link is available on the page as “Print Lock Choice”.

Q31 If I get an upgraded seat during the second round of AIQ/ Deemed/ CentralUniversity/DNB from Round 1, can I join that college directly?

A No, you will have to get a relieving letter from the earlier institute/college (of ROUND1) generated online, before you can join the next college/institution.

Q32 At the time of admission will my original certificates be retained by the allotted college/institution?

A Yes, all the participating colleges/institutions have been instructed to retain original certificates of admitted students to not block seats and prevention of multiple admissions by one candidate and release them only on up-gradation of the seat or resignation by the candidate (during the specified timelines).

Q33 Will, there be any further rounds after the completion of Round Two of All India Quota Counselling?

A Yes. As per the modified scheme, it has been directed by the Hon’ble Court to conduction of 04 rounds of counselling. Hence, 3rd round i.e. mop-up round and the fourth round i.e. stray vacancy round (AIQ/Central Institutes/University/DNB) will be conducted in AIQ by MCC.

Q34 What is the procedure for Round-3 Counseling which will be conducted by DGHS?

A The net vacant seats due to Non-Allotted, Non-Joining, or Non-Reporting of Round 2 will be published in the seat matrix and eligible candidates have to submit fresh choices and the result will be processed as per Choice & Merit for the third Round.

Also Read: MPDME Releases Tentative Schedule for NEET MDS 2024 Round 1 Counselling, details

Q35 Who will be eligible for the third Round?

A The Following categories of candidates are eligible for Mop Up Round-

a) Candidates who are registering for the first time.

b) Candidates who have registered but have not been allotted a seat in Round 1 & Round 2. Candidates who exit with forfeiture in round 2 can participate in round 3 but with fresh payment of fees.

Q36 Who will not be eligible for the third Round of Counseling?

A Candidates who have joined seats in Round 1 or Round 2 and the State Quota seat (as per the data shared by the States) and are not willing to upgrade will not be eligible or will not exit as per the scheme.

Q37 What is the schedule for Counseling and Admission to PG Courses?

A As per the schedule uploaded on the Website (www.mcc.nic.in).

Q38 What is the permissibility of students to exercise fresh choice during counselling?

A Fresh choice filling can be done in every round of counselling.

Q39 Whether counselling will be conducted for 50% of State Quota seats of Central Universities also, and for which universities?

A Yes, counselling for 50% State quota seats as per the University eligibility conditions will be conducted by MCC of DGHS, MoHFW for DU, AMU, BHU, VMMC & SJH, ABVIMS & RML Hospital and ESIC, Basaidarapur & Institutional Preference will be given to the candidates in 50% Institutional Quota. It is to be noted that the Rules & Regulations of Central Universities will apply. MCC of DGHS is only responsible for the allotment of seats.

Also Read: MP DME Announces List of Participating Colleges in NEET MDS Counselling 2024

Q40 Is it required to confirm domicile status before filling up choices?

A Candidates are advised to confirm their institutional eligibility before registering on the MCC website for 50% Institutional Quota seats of Central Universities/Institutes before opting for their seats.

Q41 Whether Up-gradation is allowed from 2nd round counselling of Deemed/ Central Universities/DNB to the third round Round counselling of DGHS for Central/Deemed Universities/DNB?

A Yes, Up-gradation allowed. (refer to the process of counselling)

Q42 Whether the Security Deposit which was submitted at the time of Registration will be refunded back in case the candidate is not allotted any seat during the rounds of online counselling conducted by MCC?

A Yes, in case the candidate is not allotted any seat in such case the Security Deposit will be refunded back to the same account of the candidate from which payment had been made.

Q43 Whether there will be two separate counselling for All India Quota and 50%Institutional Quota on separate days and separate platform?

A There is common counselling software for AIQ and Institutional Quota. Hence, the candidates of 50% Institutional Quota who are eligible for counselling should opt for the choices in order of preference between AIQ, and 50% Institutional Quota. The computer will allot the seat in order of merit and choice from the choices filled by the candidate.

Also Read: MCC NEET MDS Counselling 2024: 403 Seats Up For Grabs In All India Quota, details

Q44 Who is Eligible for the Stray Vacancy Round?

A All registered candidates who were not allotted any seat in any of the previous rounds are eligible for the stray vacancy round. However, Candidates are advised to check their eligibility conditions before applying.

Q45 Who are eligible for the “Exit with Forfeiture” option?

A Candidate who has been allotted a seat in Round 2 and Round 3 and for the Stray Vacancy Round but does not report at the college may Exit with Forfeiture. (i.e. The Security Deposit will not be refunded in such a case). Please refer to Gazette Notification No. MCI-18(1)/2018-Med./100818 of Medical Council of India dated 5th April 2018. Candidates who do not join the seat allotted to them in the Stray Vacancy Round will be debarred from participating in NEET-MDS Counselling for the next academic year i.e., 2025. Also, their security deposit will be forfeited.

Q46 Whether NRI category candidates are eligible for Paid Deemed University Seats as well?

A Yes, the NRI category candidates are eligible for seats as well. The seats will be allotted to candidates in order of merit, preference or choices filled by the candidate as per merit only.

Q47 What are the helpline numbers for PG Counselling & Finance related queries?

A The following are numbers for PG Counselling & Finance related queries: 1800 1027637, 0120- 4073500.

Also Read: NEET MDS Counselling 2024: MCC releases seat matrix, 1114 Seats available in Deemed Universities, Details

Q48 How much money will be deducted as a Transaction fee/Service fee by the College in case of an Upgrade in the next round or after Resignation?

A Candidates are advised to contact college authorities regarding Transaction fees/Service fees or other related fees before joining the college as MCC would not be responsible for any Refund related issues with the college.

Q49 I have not registered with the MCC during the first, second and third rounds, now I want to register in the Stray Vacancy round during the ongoing counselling schedule, can I do fresh registration?

A Yes fresh registration can be done during the stray vacancy round with payment of fees.

Q50 When and where this Security Deposit will be refunded?

A Security amount will be refunded only after the completion of all rounds of Counseling. MCC will notify about the completion of counselling on their portal “www.mcc.nic.in”. The Financial Custodian will initiate the refund of the security deposit within 15 days of such notification and complete it within 30 days of such notification.

Q51 If the security deposit is remitted through an unrelated card/bank account can the candidate request for the refund to a different card/bank account?

A NO. MCC will not entertain such requests. The security deposit will be refunded only to the account from where the security deposit was initially deposited. The candidates are advised to not use unrelated card/bank accounts for remitting security deposits.

Q52 What happens if the candidate, by mistake, makes more than one payment for the same Roll#?

A Candidate can approach the Financial Custodian after 10 days of closing of Registration Window. The Financial custodian will refund the excess payment, if any, within 30 days of closing of Registration Window. The financial custodian will deduct 50% of the Regn Fees or Rs.500/ whichever is less from each excess receipt refund towards Admn. expenses

Also Read: 10 Seats available In AMU Internal Quota for MCC NEET MDS Counselling 2024

Q53 Do I have to request the Financial Custodian to refund the security amount? What Is the schedule for the refund of the security amount?

A NO. Candidate need not approach the Financial Custodian for a refund of the security amount. The Medical Counselling Committee will publish the list of candidates who are eligible for the refund of the security amount on their portal “www.mcc.nic.in” once all rounds of counselling are completed. The Financial Custodian will initiate the refund of the security amount within 15 working days and complete the refund of the security deposit within 30 days of publishing the eligible list in the MCC Portal. Once the Financial Custodian completes the refund, MCC will publish the refund details along with the refund date & transaction # on their portal “www.mcc.nic.in” within 30 days of publishing the eligible list in the MCC portal. The refund will be credited, depending upon the level of digitalization of the candidate’s bank, to the candidate’s account between 2 to 15 days from the date of refund by the Financial Custodian.

Q54 Can the candidate initiate refund proceedings through a chargeback claim through the card Issuing bank?

A NO. Candidates who have been allotted Roll # should not initiate a chargeback claim through the card issuing bank. If the chargeback claim is initiated, the Financial Custodian / MCC will be restrained by the Payment Gateway Service Providers from initiating the direct refund. The candidate has to approach only their card-issuing banks for refunds if the chargeback claim is raised. For initiating a manual refund by the Financial Custodian, the candidate should withdraw the chargeback claim and produce a no objection certificate from the card issuing bank stating that the charge back claim is withdrawn & card issuing banker does not have any objection to Financial Custodian refunding the deposit. As this process takes a lot of time, the refund will be inordinately delayed. Neither the Financial Custodian nor MCC will be responsible for such delay. Hence candidates are advised not to initiate chargeback claims.

Q55 Who is the Financial Custodian?

A HLL Lifecare Ltd, a Govt. of India Undertaking under the Ministry of Health and Family Welfare is the Financial Custodian. They will, on behalf of MCC, collect non-refundable Registration Fees and refundable security deposit from the candidates and refund the security deposit to the eligible candidates.

Also Read: 25 Seats Up For Grabs In DU, BHU Internal Quota for NEET MDS Counselling, MCC seat matrix released

Q56 How to contact the Financial Custodian?

A For Refund Related Issues: “financemcc@lifecarehll.com”

1 For all other issues: “callcentremcc@lifecarehll.com” or 18001027637.

2 The Financial custodian will respond only to the mail through a mail ID registered with MCC.

3 Direct queries to MCC will not be entertained.

4 For refund-related issues, the Candidate can approach the Financial Custodian only after 10 days of closing the Counselling Window or 15 days of publication of “Refund Details” in the MCC Portal.

Q57 Will the Medical Counselling Committee bear the bank charges incurred by the candidate while registering for counselling?

A NO. Bank Charges if any, incurred by the candidate should be borne by the candidate only. However, it is advised that the candidate should prefer to use the method wherein the bank transaction charges are minimal; like net banking.

Q58 Can the candidate remit the Registration Fee and Security Deposit from the NRI Account?

A NO. MCC cannot, as per Reserve Bank of India (RBI) Rules, refund the security deposit to the NRI Account. If the candidate wants to use the funds available in his/ her NRI Account for registering for counselling, he /she has to first transfer funds from the NRI Account to the NRO Account and from the NRO Account to MCC. The refund from MCC will be credited to the NRO Account only.

Q59 Will MCC pay interest on the refundable security deposit?

A NO. MCC will not pay interest on the refundable security deposit.

Violence at UCMS GTB Hospital: Mob Attacks On-duty Doctors, RDA declares Strike

New Delhi: Resident doctors at the University College of Medical Sciences (UCMS) and Guru Teg Bahadur (GTB) Hospital recently had to face violence when a mob of 50-70 individuals armed with assault weapons stormed the Gynaecology Department, assaulted the on-duty doctors, threatened the staff and damaged the hospital property.

Protesting against this, the Resident Doctors’ Association (RDA) of UCMS and GTB Hospital has given a call for a strike. They have stated that their strike will continue until an institutional FIR is registered in this connection. However, the emergency services are being kept operational, said a member of the RDA at the medical college.

When asked about the incident, a member of the RDA informed Medical Dialogues, on the condition of anonymity, that the incident of violence took place with respect to the treatment of a patient who underwent normal vaginal delivery. However, after the delivery, the patient faced Post-Partum Hemorrhage (PPH) and the patient’s condition started deteriorating.

While the doctors were trying to manage the situation, an attendant of the patient came inside and started shouting at everyone creating a hindrance in the treatment process. The attendant called around 50-60 people. Meanwhile, the doctors kept on resuscitating the patient. However, the mob attacked one Senior and one Junior Resident at the hospital. When the patient was taken to the OT, the mob allegedly entered the Operation Theatre as well. They created a ruckus and misbehaved with the Anaesthetist.

Issuing a Press Release today, the RDA at the medical institute stated, “UCMS & GTB Hospital witnessed a shocking act of violence in the Gynaecology Department. A mob of 50-70 individuals armed with assault weapons stormed the department, threatening the staff, breaking doors and wreaking havoc. This brazen attack has put the lives of our medical staff and patients in grave danger.”

The association further announced its decision to initiate a strike and said, “We, the Senior Residents and Junior Residents of UCMS & GTB Hospital are outraged by this incident and taking a firm stand. Effective immediately, we are going on strike until our demand for the registration of an institutional FIR is met. During this period, only emergency services will be operational.”

RDA has demanded immediate implementation of robust security measures in all hotspot areas of the hospital including the deployment of security personnel/bouncers in the hospital. Demanding strict action against the culprits, the association has clarified that it would not tolerate any more threats to the safety of either the doctors or the patients.

Also Read: Violence at Raiganj Medical College: On-duty doctors suffer injuries in mob attack, Colleagues boycott OPD

NPPA Fixes Retail price of 54 formulations, Details

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, the Government of India, has fixed retail prices for 54 formulations under the Drugs (Prices Control) Order, 2013.

The list of formulations includes Theon Pharmaceuticals/Alkem Laboratories Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets, Theon Pharmaceuticals/ Torrent Pharmaceutical’s Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets, Theon Pharmaceuticals/Zydus Healthcare’s Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets, Theon Pharmaceuticals/Micro Lab’s Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets, Theon Pharmaceuticals/MSN Laboratories’ Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets and others.

This comes after in exercise of the powers conferred by paragraphs 5, 11, and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30^th May 2013 and S. O. 5249(E) dated 11^th November 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (NPPA), has fixed, the price as specified in column (6) of the Table herein below as the retail price, exclusive of Goods and Services Tax, if any, about the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Sl. No.	Medicines	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Linagliptin, Dapagliflozin, and Metformin Hydrochloride (SR) Tablets	Each film-coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Alkem Laboratories Ltd.	20.78
2	Linagliptin, Dapagliflozin, and Metformin Hydrochloride (SR) Tablets	Each film-coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd.	19.00
3	Linagliptin, Dapagliflozin, and Metformin Hydrochloride (SR) Tablets	Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Zydus Healthcare Ltd.	20.78
4	Linagliptin, Dapagliflozin, and Metformin Hydrochloride (SR) Tablets	Each film-coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Micro Labs Limited	15.89
5	Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets	Each film-coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s MSN Laboratories Pvt. Ltd.	19.64
6	Linagliptin, Dapagliflozin and Metformin	Each film coated bilayer tablet contains: Linagliptin 5mg	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Lupin Limited	20.78

Sl. No.	Medicines	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
	Hydrochloride (SR) Tablets	Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form)
7	Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets	Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Mankind Pharma Limited	20.78
8	Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets	Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Intas Pharmaceuticals Ltd.	20.78
9	Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets	Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd.	18.00
10	Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets	Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Alkem Laboratories Ltd.	19.64
11	Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets	Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Zydus Healthcare Ltd.	19.64
12	Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets	Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s MSN Laboratories Pvt. Ltd.	18.75
13	Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets	Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Intas Pharmaceuticals Ltd.	19.64

Sl. No.	Medicines	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
14	Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets	Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Micro Labs Limited	15.00
15	Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets	Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Mankind Pharma Limited	19.64
16	Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets	Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Lupin Limited	19.64
17	Glimepiride & Sitagliptin Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Glimepiride IP 2 mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Mankind Pharma Limited	15.38
18	Glimepiride & Sitagliptin Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Glimepiride IP 2 mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Limited	15.38
19	Glimepiride & Sitagliptin Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Glimepiride IP 1 mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Mankind Pharma Limited	13.70
20	Glimepiride & Sitagliptin Tablet	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Glimepiride IP 1mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Limited	13.70
21	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained release) Metformin Hydrochloride IP 500mg (as Sustained Release)	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd./ M/s Aristo Pharmaceuticals Pvt. Ltd.	13.78
22	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained release) Metformin Hydrochloride IP 1000mg (as Sustained Release)	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd./ M/s Aristo Pharmaceuticals Pvt. Ltd.	15.27
23	Sitagliptin Phosphate, Metformin	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Primus	12.86

Sl. No.	Medicines	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
	Hydrochloride and Glimepiride Tablets	eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 1 mg		Remedies Pvt. Ltd.
24	Sitagliptin Phosphate, Metformin Hydrochloride and Glimepiride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 2 mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd.	14.65
25	Bisoprolol Fumarate and Telmisartan Tablets	Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg Telmisartan IP 40 mg	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Cipla Limited	9.65
26	Bisoprolol Fumarate and Telmisartan Tablets	Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg Telmisartan IP 40 mg	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Cipla Limited	11.21
27	Bictegravir, Emtricitabine & Tenofovir Alafenamide Tablets	Each film coated tablet contains: Bictegravir Sodium eq. to Bictegravir 50mg Emtricitabine IP 200mg Tenofovir Alafenamide Fumarate IP eq. to Tenofovir Alafenamide 25mg	1 Tablet	M/s Hetero Labs Limited / M/s Emcure Pharmaceuticals Limited	132.58
28	Omeprazole + Domperidone Tablets	Each gasto-resistant tablet contains: Omeprazole Magnesium BP eq. to Omeprazole 20mg Domperidone IP 10mg	1 Tablet	M/s Next Wave (India) / M/s Mankind Prime Labs Pvt. Ltd.	3.85
29	Ceftriaxone and Sulbactam Injection	Each vial contains: Ceftriaxone Sodium IP eq to Ceftriaxone 250mg Sulbactam Sodium IP eq to Sulbactam 125mg	1 Vial	M/s Zen Pharma (P) Limited / M/s Hetero Healthcare Ltd.	58.90
30	Ceftriaxone and Sulbactam Injection	Each vial contains: Ceftriaxone Sodium IP eq to Ceftriaxone1000mg Sulbactam Sodium IP eq to Sulbactam 500mg	1 Vial	M/s Zen Pharma (P) Limited / M/s Hetero Healthcare Ltd.	143.92
31	Tranexamic Acid and Mefenamic Acid Tablets	Each film coated tablet contains: Tranexamic Acid IP 500mgMefenamic Acid IP 250mg	1 Tablet	M/s Aagya Biotech Pvt. Ltd. / M/s J. B. Chemicals & Pharmaceuticals Ltd.	30.43
32	Donepezil Hydrochloride and Memantine Tablets	Each film coated Tablet contains: Donepezil Hydrochloride IP 10mg Memantine IP 10mg	1 Tablet	M/s Savi Health Science / M/s Alkem Laboratories Ltd.	19.11
33	Calcium & Vitamins D3 Tablet	Each film coated tablet contains: 1.25g of Calcium Carbonate from an organic source (Oyster shell) eq. to Elemental Calcium 500mg Cholecalciferol IP (Vitamin D3) 500IU (as stabilized form)	1 Tablet	M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Sun Pharmaceutical Industries Limited	7.82
34	Amoxycillin and Potassium Clavulanate Oral Suspension IP	Each 5ml of the reconstituted suspension contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 600mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 42.9mg	1 ml	M/s ALPS Communication Pvt. Ltd. / M/s Galpha Laboratories Ltd.	3.17
35	Calcitriol, Calcium & Zinc Softgel capsule	Each soft Gelatin Capsule contains: Calcium Carbonate IP 500mg eq. to Elemental Calcium 200mg Calcitriol IP 0.25mcg Zinc Sulphate Monohydrate IP eq. to Elemental Zinc 7.5mg	1 Capsule	M/s Titanium Technologies (India) Pvt. Ltd. / M/s J.B. Chemicals & Pharmaceuticals Ltd.	15.94

Sl. No.	Medicines	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
36	Mupirocin and Sucralfate Ointment	Composition: Mupirocin IP 2% w/w Sucralfate IP 7% w/w	1 gram	M/s Stedman Pharmaceuticals Pvt. Ltd.	17.05
37	Cefixime & Ofloxacin for Oral Suspension	Each 5ml of the reconstituted suspension contains: Cefixime Trihydrate IP eq. to cefixime Anhydrous 50mg Ofloxacin IP 50mg (This pack contains 20ml of sterile water for reconstitution)	1 ml	M/s Theon Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd.	1.90
38	Dextromethorphan Hydrobromide, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Tablets	Each film coated tablet contains: Dextromethorphan Hydrobromide IP 10mg Chlorpheniramine Maleate IP 2mg Phenylephrine Hydrochloride IP 5mg	1 Tablet	M/s J.K. Print Pack (Pharma Division) / M/s Cadila Pharmaceuticals Ltd.	4.69
39	Telmisartan, Chlorthalidone & Cilnidipine tablets	Each film coated tablet contains: Telmisartan IP 40mg Chlorthalidone IP 6.25mg Cilnidipine IP 10mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Indchemie Health Specialities Pvt. Ltd.	14.07
40	Tranexamic Acid Sustained Release Tablets	Each sustained release film coated tablet contains: Tranexamic Acid IP 750mg	1 Tablet	M/s Macleods Pharmaceuticals Ltd.	19.09
41	Atorvastatin & Aspirin Capsule	Each hard gelatine capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 10mg (As granules), Aspirin (As Gastro-resistant tablet IP) IP 75mg	1 Capsule	M/s Unison Pharmaceuticals Pvt. Ltd.	2.68
42	Itraconazole Capsules 130mg (Supra- Bioavailable Formulation)	Each hard gelatin capsule contains: Itraconazole BP 130mg	1 Capsule	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.	19.73
43	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet Contain: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Glenmark Pharmaceuticals Limited	14.00
44	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet Contain: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Glenmark Pharmaceuticals Limited	15.32
45	Clindamycin & Nicotinamide Gel	Composition: Clindamycin Phosphate IP eq. to Clindamycin 1.0% w/w Nicotinamide IP 4.0% w/w	1 Gram	M/s Pharma Force Labs / M/s Cadila Pharmaceuticals Ltd.	5.35
46	Lidocaine & Prilocaine Gel	Composition: Lidocaine IP 2.50% w/w Prilocaine IP 2.50% w/w Sorbic acid IP (as preservative) 0.08% w/w	1 Gram	M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Ra-Vish Wellness Pvt. Ltd.	11.39
47	Moxifloxacin Hydrochloride & Dexamethasone Eye Drops	Composition: Moxifloxacin Hydrochloride BP eq. to Moxifloxacin 0.5% w/v Dexamethasone Sodium Phosphate IP 0.1% w/v	1 ml	M/s Aurolab	14.00

Sl. No.	Medicines	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
48	Metoprolol Succinate Extended Release, Amlodipine & Telmisartan Tablet	Each film coated bilayered tablet contains: Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate 50mg (As Extended release) Amlodipine Besilate IP eq. to Amlodipine 5mg Telmisartan IP 40mg	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd.	14.50
49	Escitalopram Oxalate Tablets	Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 15mg	1 Tablet	M/s Merril Pharma Pvt. Ltd. / M/s Alkem Laboratories Limited	12.39

Sl. No.	Medicines	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1.	Telmisartan, Chlorthalidone and Cilnidipine Tablet	Each film-coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10mg Chlorthalidone IP 6 .25mg	1 Tablet	M/s Corona Remedies Pvt. Ltd.	7.14
2.	Telmisartan and Chlorthalidone Tablet	Each film coated tablet contains: Telmisartan IP 40mg Chlorthalidone IP 6.25mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s La Renon Healthcare Pvt. Ltd.	7.28
3.	Telmisartan and Amlodipine Tablet	Each uncoated bilayered tablet contains: Telmisartan IP 40mg Amlodipine Besilate IP eq. Amlodipine 5mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s La Renon Healthcare Pvt. Ltd.	7.31
4.	Telmisartan and Cilnidipine Tablet	Each film coated tablet contains: Telmisartan IP 40mg Cilnidipine IP 10mg	1 Tablet	M/s Corona Remedies Pvt. Ltd.	5.90
5.	Telmisartan, Hydrochlorothiazide and Amlodipine Tablets	Each uncoated bilayered tablet contains: Telmisartan IP 40mg Hydrochlorothiazide IP 12.5mg Amlodipine Besylate eq. to Amlodipine 5mg	1 Tablet	M/s Corona Remedies Pvt. Ltd.	4.50

The notice further added

The manufacturer of the above-mentioned formulations i.e., ―new drug‖ under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above-said table.
The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
The above mentioned retail price applies only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/ marketing companies.
In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
Consequent to the fixation of the retail price of such formulation as specified in column (2) of the above table with the strength and name of manufacturer and marketing companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that manufacturer and marketing Companies as specified in corresponding entries in Column (2),(3) and (5) thereof, if any, issued before this notification, stand(s) superseded.

To view the notice click the below link:

https://medicaldialogues.in/pdf_upload/aba40e1cc7fcb1f3bc6943f313d3aec4-241367.pdf

Also Read:NPPA Revises Ceiling Price of FDC Budesonide Plus Formoterol Inhalation

COVID vaccine supply deal dispute: JnJ to pay USD 50 million to Emergent

Emergent BioSolutions has said that Johnson & Johnson has agreed to settle claims arising from the termination of the manufacturing deal for the latter’s COVID-19 vaccine with a payment of USD 50 million.

In 2022 J&J informed Emergent of its decision to terminate the deal, citing breaches including failure to supply COVID-19 vaccine drug substance on the part of the contract manufacturer.

Emergent had said J&J breached the agreement by failing to buy the minimum quantity of COVID-19 vaccines made by the company.

According to Reuters, under the five-year agreement , signed in 2020, Emergent would provide contract manufacturing services to produce the COVID-19 vaccine drug substance for commercial manufacturing. It was valued at about $480 million for the first two years.

The U.S. health regulator had limited the use of the J&J vaccine in 2022 due to the risk of a rare blood clotting syndrome.

Read also: JnJ submits application to USFDA for Subcutaneous amivantamab for patients with EGFR-mutated non-small cell lung cancer

From V. P. Shantha to D. K. Gandhi: Evolving Perspectives on Doctors Liability in Healthcare

In
1996, the landmark IMA v/s V.P. Shantha case, which was decided by a divisional
bench of the Supreme Court comprising three judges, set a pivotal precedent by
affirming that doctors are encompassed within the purview of the Consumer
Protection Act (CPA).

This ruling also signalled a significant shift in the
understanding of the Act, implying that other professionals, such as those in
the legal profession, could also potentially be impacted and brought under the
ambit of the CPA. The National Consumer Commission held that legal
professionals do come under the CPA, based on the findings of V.P. Shantha
v/s IMA.

However,
the recent judgment of the Honourable Supreme Court (Justices Bela Trivedi and
Pankaj Mithal) in BCI & Others v/s D.K. Gandhi emphasized that lawyers
would not be held liable under the Consumer Protection Act,
2019 (CPA) for any alleged deficiencies in providing their professional
services while representing clients.

It was argued that, unlike the medical
profession, where scientific standards exist to decide the standard of care,
there is no universal standard of care or objective test that exists or can be
prescribed as the threshold in the case of the legal profession to adjudicate
upon the question of abdication of duty of care.

This
case once again renews the ongoing debate within the medical community: should medical doctors be equated with other service providers such as
carpenters, bankers, plumbers, and so on, under consumer protection laws?

While
standard treatment guidelines are in place, the intricate nature of medicine,
known for its lack of exact science, poses unique challenges in each patient’s
case.

Even with the application of the best standards of care, desired outcomes
may not always be achieved. Medical professionals are trained to provide
optimal care ethically, with outcomes largely dependent on the patient’s
condition.

The
Supreme Court focused on the legislative intent and whether the legislature
ever intended to include professionals within the purview of the CPA. In
answering this question, the court observed that “Professionals could not
be called businessmen or traders, nor could clients or patients be called
consumers.”

It is also required to bear in mind that the terms ‘business’
or ‘trade’ having a commercial aspect involved, could not be used
interchangeably with the term ‘profession’ which normally would involve some
branch of learning or science.

The very purpose and object of the CPA, 1986, as re-enacted in 2019, was to provide protection to the consumers from unfair trade
practices and unethical business practices only. There is nothing on record to
suggest that the legislature ever intended to include professions or
professionals within the purview of the Act.

The
court went further and examined whether the legal profession is distinct from
other professions, even when considered in light of the V.P. Shantha case
logic, and concluded that the legal profession cannot be compared with any
other profession, and particularly not with the medical profession.

In this
context, one of the judges categorically observed that the V. P. Shantha case
be re-examined by the constitutional bench for its correctness. The second Judge
(Hon’ble Justice Pankaj Mithal) compares the Indian consumer protection law
with many comparable laws from other jurisdictions.

From that comparative
analysis, he states that “in India, the services of professionals, more
particularly that of lawyers, have to be excluded from consumer protection law.”

The submission to the Chief Justice of India for revisiting the V. P. Shantha
case judgment merely made as an obiter by one of the judges deciding the case,
raises the technical point of whether the CJI is obliged to constitute the
constitutional bench in this regard, or whether it is only an
observation.

The
ongoing debate regarding the accountability of medical professionals under
consumer protection laws highlights important considerations, especially amidst
the increasing practice of defensive medicine, leading to higher costs. The
essential trust between doctors and patients is gradually diminishing.

At this
juncture, it may be appropriate to reevaluate the current framework to strike a
balance between safeguarding consumer rights and fostering a medical
environment that prioritizes patient welfare and trust.

Disclaimer: The views expressed in this article are of the author and not of Medical Dialogues. The Editorial/Content team of Medical Dialogues has not contributed to the writing/editing/packaging of this article.

Ministry’s Department of Health Research Invites research proposals for short-term studentship for 3rd-year MBBS, BDS students, details

New Delhi- The Human Resource Development (HRD) Scheme aims to provide opportunities for advanced training in biomedical and health research to create a pool of trained & experienced human resources in India. On this, the Department of Health Research (DHR) is inviting online research proposals for the year 2024-25 from eligible applicants from NMC/DCI-recognised medical/dental colleges.

The applications for the research proposals can be submitted online through the DHR web portal. The last date of receipt of full-length research proposals is 25 July 2024 till 05:00 PM.

Below are the eligibility, duration and financial support of the research proposals for the year 2024-25.

Also Read: NTA Invites Applications for DHR-ICMR Non-Medical Fellowship for PhD- Biomedical Research Eligibility Test- BRET 2024, Know all details here

ELIGIBILITY

As per the notice in this regard, the applicant should be in the 3rd year of his/her MBBS/BDS course. However, final Year students will not be eligible.

DURATION

The research duration is 3 months and is to be completed within 1 year from the selection for the STS.

COMPONENT

Short Term Studentship (STS) specifically for current 3rd year MBBS/BDS Students in 2024-25. This is One Time Measure (OTM) introduced specifically for the year 2024-25, to accommodate the shift to the revised Guidelines. However, the third-year MBBS/BDS students will not be eligible to apply for the STS programme from 2025-26 onwards in the light of the Guidelines revision.

Also Read: ICMR-NICPR To Hold Hands-on Training in HPV DNA Diagnostics for Medical Professionals, details

FINANCIAL SUPPORT

A stipend of Rs 30,000 will be given upon the submission and approval of the final report.

IMPORTANT POINTS

1 All projects involving research on human beings/ animals must be cleared by the Human Ethics Committee/ Animal Ethics Committee of the respective institute.

2 All Fellowships are subjected to approval by the Technical Evaluation Committee / Project Approval Committee and the availability of funds under the Scheme.

The Department of Health Research (DHR) was created as a separate Department under the Ministry of Health and Family Welfare on 17 September 2007 by amending the Government of India (Allocation of Business) Rules, 1961. The department became functional from November 2008 with the appointment of the first Secretary of the department.

To view the notice, click the link below

https://medicaldialogues.in/pdf_upload/call-for-proposal-24-june-2024-242109.pdf

South Korea threatens to reduce Trainee Doctor Quota unless hospitals process resignations by next week

Seoul: The South Korean government has informed hospitals that it will decrease next year’s quota of trainee doctors unless they accept resignations by next week.This move is aimed at urging trainee doctors, who have been on strike against medical reforms, to return to their posts

The move is seen as a measure to put pressure on trainee doctors, who have left their worksites since late February in protest of the medical reform, to return to hospitals, Yonhap news agency reported.

According to an IANS report, a notice was sent to training hospitals on Monday, when the government announced a decision to withdraw its plan to take administrative steps, including the suspension of medical licences, against striking trainee doctors to seek a breakthrough in monthslong medical service disruptions.

Also Read:South Korea’s Medical Reform Plan: Medical Professors to launch indefinite walkout from July 12

If the hospitals accept the resignations of the trainee doctors by next Monday, the move is expected to help them find jobs at other hospitals.

The notice also stated that trainee doctors who reapply for the training programme starting in September will receive special treatment, such as an exemption from the rule prohibiting repeat applications to a department within the same year, the report said.

Still, it remains to be seen how many striking doctors will return to work following the government’s decision to abandon all punitive steps against them.

More than 12,000 trainee doctors, over 90 per cent of the total, have been on strike in the form of mass resignations since February 20 in protest of the government’s bid to hike medical school admissions quota.

Previously, the government had said it would cope with the prolonged walkout under the law. Still, Health Minister Cho Kyoo-hong said on Monday that it is “more urgent” to end the walkout by withdrawing punitive measures against trainee doctors, news agency IANS reported.

Monday’s decision has sparked criticism that it hurts the principle of fairness over the government’s handling of labour actions as doctors are allowed to go unpunished despite illegal acts, the report said.

Also Read:Medical School Quota Hike: South Korea pledges firm response to illegal acts ahead of Doctors’ collective action

Combining popular diabetes drugs offers complementary heart and kidney benefits, research finds

New research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and kidney disease in patients with diabetes. The findings were published today in The Lancet Diabetes & Endocrinology and presented in May at the 61st European Renal Association Congress in Stockholm, Sweden.